Navigation Links


Topical at Biology News

Topical treatment shown to inhibit HIV and herpes simplex virus infection

Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex Virus. The study, presented at the 12th Conference on Retroviruses and Opportunistic Infections, is the first to show that a gel can retain anti-viral activity within the human vagina. The study, which was fund...
Topical at Biology Products
Topical at Biology Technology
Topical at Medicine News

Topical Quinolone effective in controlling eardrum perforations

Topical administration of Quinolone antibiotics for eardrum perforations has been found to be more effective in treating the disease than the use of systemic antibiotics//. Dr. Carolyn Macfadyen, Research Associate, International Health Research Group in the Liverpool School of Tropical Medicine, UK has reported in a review published in The Cochrane Library that topical quinolone are better than...

Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis

CHICAGO - Researchers suggest a short-term application of topical corticosteroids and maintenance with a less potent agent for patients// with intertriginous psoriasis (IP), according to a study published in the September issue of Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis is an inflammatory skin disease. In a subset of patients, psoriasis is located in the...

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

Replidyne, Inc. today announced results from three Phase I trials studying REP8839, a novel topical antibiotic that has shown potent in vitro activity against major skin pathogens including methicillin-resistant S. aureus (MRSA). The results of the Phase I trials show that topically applied REP8839 appears safe, well-tolerated and associated with low systemic exposure, or drug abso...
Topical at Medicine Products

Chito-Seal Topical Hemostasis Pad

Description:The Chito-Seal Topical Hemostasis Pad is intended for use in the management of bleeding wounds such as vascular access sites and percutaneous catheters or tubes. The Pad is coated with Abbotts proprietary chitosan gel, a powerful hemostatic agent. Chitosan gel is twice as chemically active as chitin, the marine biopolymer from which it is derived. When placed over the puncture site, it becomes a...
Company:Abbott Vascular

Povidone Iodine Topical Gel

Description:Povidone Iodine Topical Gel is a viscous antimicrobial that contains 10% Povidone Iodine USP, 1% available Iodine for broad-spectrum germicidal action. As a preoperative patient prep, Povidone Iodine Gel helps to minimize the pooling of prepping solutions under the patient, thus reducing the chance of patient burns. Povidone Iodine Topical Gel is film forming, creating a desirable residual microb...
Company:APLICARE Inc.

Povidone Iodine Topical Gel (Flip-top Cap)

Description:This multi-purpose topical gel contains 10% Povidone Iodine USP, 1% available Iodine, for broad-spectrum germicidal action. As a pre-operative prep, Povidone Iodine Gel helps to minimize the pooling of prepping solutions under the patient, thus reducing the chance of patient burns. The Gel is also approved as a one step gel for venipuncture site preparation prior to blood and plasma collection. P...
Company:APLICARE Inc.
Topical at Medicine Technology

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

LOUISVILLE, Colo., June 26, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. today announced results from three Phase I trialsstudying REP8839, a novel topical antibiotic that has shown potentin vitro activity against major skin pathogens includingmethicillin-resistant S. aureus (MRSA). The results of the Phase Itrials show that topically applied REP8839 appears safe,well-tolerated and asso...

NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis

ANN ARBOR, Mich., May 22, 2007 /PRNewswire/ -- NanoBioCorporation, a biopharmaceutical company developing novel productsfor the treatment and prevention of serious infections, todayannounced positive safety data from its Phase 1 clinical study ofNB-002, the company's drug candidate currently in a Phase 2clinical trial for the topical treatment of onychomycosis. The Phase 1 clinical...

Apollo develops needle-free topical vaccine

SYDNEY, April 30, 2007-Australian bio-discovery company ApolloLife Sciences has released results of preliminary trials of itspatented needle-free vaccine technology, which delivers tetanusvaccine transdermally (through the skin) without the need for aninjection. According to Apollo CEO John Priest, the research points the wayto the possibility that flu injections may soon be a thin...

Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b

AURORA, ON, March 30, 2007 /PRNewswire-FirstCall/ - Helix todayannounced positive results from its phase II clinical study of itsTopical Interferon Alpha-2b in women with human papilloma virus(HPV) induced low-grade cervical lesions. The study showed a clinically efficacious response to treatmentin nearly half of the treated patients. In addition, the pr...
Other TagsClearviewImmunoCard
(Date:5/16/2008)...ffices of Howard G. Smith,announces a June 9, 2008...ecurities class action lawsuit filed on behalf of ...e common stock of Inverness Medical,Innovations, I... IMA ) in the,Company,s secondary public offering .... The shareholder lawsuit is pending in the United...
(Date:5/16/2008)...s want agency to act, not wait years , ,...umer drug ads on television should include a toll-...port adverse side effects, U.S. health experts sug...hat advises the U.S. Food and Drug Administration....A for print ads. At Friday,s meeting, the panel di...
(Date:5/16/2008)...HINGTON, May 16 /PRNewswire-USNewswire/ -- More th...s in the Greater Portland, Oregon and,Vancouver, W...ract as,Teamsters., "The Teamsters are pleased th...act that gives them job protection and a secure re... Jim Hoffa., The workers, both full-time and part...
(Date:5/16/2008)...fit from calcitriol, an oral form , , FR...vitamin D may cut the risk of death for people wit...ut one quarter, a new study suggests. , During...se being treated with calcitriol, an oral form of ...th lowered by 26 percent when compared with those ...
Breaking Medicine News(10 mins):Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 2Health News:FDA Panel Considers Toll-Free Number for TV Drug Ads 3Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2
(Date:5/15/2008)...ge has long been a concern for environmental scien... problem of excessive reactive nitrogen in the env...f environmental scientists who study how the eleme...lters local and global ecosystems and potentially ...environmental scientists bring the problem to the ...
(Date:5/15/2008)... has developed a simple artificial cell with which...wo of the most basic cell components: the cell mem... surrounds the structures in living cells. The wo...ke advantage of properties of cell organization to...findings will be published later this month (late ...
(Date:5/15/2008)...ether bacteria stick to surfaces depends partly on...created ultrathin films made of polymers that coul... to control microbe accumulation. , The inexpens...e layer of protection for the health care industry...red infections, which take the lives of 100,000 pe...
(Date:5/15/2008)...itrogen compounds emitted into the atmosphere by h...use of nitrogen fertilizers enters the oceans and ...m the atmosphere, concluded a team of internationa...shed Professor of Oceanography and Atmospheric Sci... institutions around the world presented its concl...
Breaking Biology News(10 mins):Addressing the 'nitrogen cascade' 2Addressing the 'nitrogen cascade' 3Simple model cell is key to understanding cell complexity 2MIT crafts bacteria-resistant films 2MIT crafts bacteria-resistant films 3Atmosphere threatened by pollutants entering ocean, prof says 2Atmosphere threatened by pollutants entering ocean, prof says 3Premier Research Appoints Global Head of Human Resources 642 1Premier Research Appoints Global Head of Human Resources 642 2Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 297 1Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 297 2Once a Year Bone Drug Lowers Fracture Risk 1455 1Once a Year Bone Drug Lowers Fracture Risk 1455 2Once a Year Bone Drug Lowers Fracture Risk 1455 3DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 1DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 2DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 3DRAXIS to Present at the 2007 UBS Global Life Sciences Conference 1451 4
Other Contentssepticsepticsepticsepticseptumserologyserologyironironironironironironironironcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumcalciumphosphorusphosphorusphosphorusphosphorusphosphorusphosphoruseducationeducationeducationeducationeducationeducationeducationeducation